Live News Categoriesequity

Pila Pharma AB (publ) (PILA.ST) News

Follow Pila Pharma AB (publ) (PILA.ST) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 1 public stories across 1 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.

Symbol PILA.ST Asset equity Sector Markets 90 days 1 Last 1.665 Updated Sep 29, 2026, 11:06 AM UTC Open live news feed Open PILA.ST chart & news

M Pila Pharma starts enrollment for PP-CT04 Part 1 obesity trial of XEN-D0501 Pila Pharma initiated its first clinical site for PP-CT04, enabling enrollment to begin in Part 1 of a 12-week obesity trial testing oral TRPV1 antagonist XEN-D0501. Part 1 enrolls 8 participants to generate initial safe EQUITY | Sep 29, 2026, 11:06 AM UTC